b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="ijpharsci" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2852069/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852069/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Indian Journal of Pharmaceutical Sciences" /><meta name="citation_title" content="In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses" /><meta name="citation_authors" content="P. Selvam, N. Murgesh, M. Chandramohan, E. De Clercq, E. Keyaerts, L. Vijgen, P. Maes, J. Neyts, M. V. Ranst" /><meta name="citation_date" content="Jan-Feb 2008" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="70" /><meta name="citation_firstpage" content="91" /><meta name="citation_doi" content="10.4103/0250-474X.40339" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2852069/?report=abstract" /><meta name="citation_pmid" content="20390088" /><meta name="DC.Title" content="In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Wolters Kluwer -- Medknow Publications" /><meta name="DC.Contributor" content="P. Selvam" /><meta name="DC.Contributor" content="N. Murgesh" /><meta name="DC.Contributor" content="M. Chandramohan" /><meta name="DC.Contributor" content="E. De Clercq" /><meta name="DC.Contributor" content="E. Keyaerts" /><meta name="DC.Contributor" content="L. Vijgen" /><meta name="DC.Contributor" content="P. Maes" /><meta name="DC.Contributor" content="J. Neyts" /><meta name="DC.Contributor" content="M. V. Ranst" /><meta name="DC.Date" content="Jan-Feb 2008" /><meta name="DC.Identifier" content="10.4103/0250-474X.40339" /><meta name="DC.Language" content="en" /><meta property="og:title" content="In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses" /><meta property="og:type" content="article" /><meta property="og:description" content="4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N(4,6-dimethyl-2-pyrimidiny)benzene sulphonamide and its derivatives were evaluated for antiviral activity against Pathogenic viruses such as Hepatitis C Virus and SARS-CoV in Vero and Huh 5-2 cells, respectively. ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852069/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-ijpharsci.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2852069/epub/" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B60A0E9A36DC10000000008830882.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/978/">Indian J Pharm Sci</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/186272/">v.70(1); Jan-Feb 2008</a></li><li class="accid">PMC2852069</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-ijpharsci.gif" alt="Logo of ijpharsci" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="poly" coords="0,0,500,0,500,21,400,21,400,75,0,75" alt="Home" title="Home" href="http://www.ijpsonline.com" ref="reftype=publisher&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="410,24,500,37" alt="Current issue" title="Current issue" href="http://www.ijpsonline.com/currentissue.asp" ref="reftype=publisher&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="410,42,500,53" alt="Instructions" title="Instructions" href="http://www.ijpsonline.com/contributors.asp" ref="reftype=publisher&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="410,59,500,75" alt="Archives" title="Archives" href="http://www.ijpsonline.com/backissues.asp" ref="reftype=publisher&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Indian J Pharm Sci</span>. 2008 Jan-Feb; 70(1): 91\xe2\x80\x9394. </span></div><div>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.4103%2F0250-474X.40339" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.4103/0250-474X.40339</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2852069</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20390088">20390088</a></div></div></div></div><h1 class="content-title"><em>In Vitro</em> Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Selvam%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861106624" co-class="co-affbox">P. Selvam</a>,<sup></sup><sup>*</sup> <a href="/pubmed/?term=Murgesh%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139827219488" co-class="co-affbox">N. Murgesh</a>,<sup>1</sup> <a href="/pubmed/?term=Chandramohan%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861103280" co-class="co-affbox">M. Chandramohan</a>,<sup>2</sup> <a href="/pubmed/?term=De%20Clercq%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861101056" co-class="co-affbox">E. De Clercq</a>,<sup>3</sup> <a href="/pubmed/?term=Keyaerts%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861098832" co-class="co-affbox">E. Keyaerts</a>,<sup>3</sup> <a href="/pubmed/?term=Vijgen%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861779616" co-class="co-affbox">L. Vijgen</a>,<sup>3</sup> <a href="/pubmed/?term=Maes%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861777392" co-class="co-affbox">P. Maes</a>,<sup>3</sup> <a href="/pubmed/?term=Neyts%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861775168" co-class="co-affbox">J. Neyts</a>,<sup>3</sup> and  <a href="/pubmed/?term=Ranst%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088" class="affpopup" co-rid="_co_idm140139861772944" co-class="co-affbox">M. V. Ranst</a><sup>3</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140139861106624"><h3 class="no_margin">P. Selvam</h3><p>Arulmigu Kalasalingam College of Pharmacy, Krishnankoil - 626 190, India</p><div>Find articles by <a href="/pubmed/?term=Selvam%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">P. Selvam</a></div></div><div id="_co_idm140139827219488"><h3 class="no_margin">N. Murgesh</h3><p><sup>1</sup>Institute of Pharmacology, Madurai Medical College, Madurai - 625 020, India</p><div>Find articles by <a href="/pubmed/?term=Murgesh%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">N. Murgesh</a></div></div><div id="_co_idm140139861103280"><h3 class="no_margin">M. Chandramohan</h3><p><sup>2</sup>Bharat Ratna Kamarajar Liver Hospital and Research Center, Madurai - 625 001, Belgium</p><div>Find articles by <a href="/pubmed/?term=Chandramohan%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">M. Chandramohan</a></div></div><div id="_co_idm140139861101056"><h3 class="no_margin">E. De Clercq</h3><p><sup>3</sup>Raga Institute for Medical Research, Katholieke Universiteit-Leuven, Minder broederstraat 10, LeuvenB-3000, Belgium</p><div>Find articles by <a href="/pubmed/?term=De%20Clercq%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">E. De Clercq</a></div></div><div id="_co_idm140139861098832"><h3 class="no_margin">E. Keyaerts</h3><p><sup>3</sup>Raga Institute for Medical Research, Katholieke Universiteit-Leuven, Minder broederstraat 10, LeuvenB-3000, Belgium</p><div>Find articles by <a href="/pubmed/?term=Keyaerts%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">E. Keyaerts</a></div></div><div id="_co_idm140139861779616"><h3 class="no_margin">L. Vijgen</h3><p><sup>3</sup>Raga Institute for Medical Research, Katholieke Universiteit-Leuven, Minder broederstraat 10, LeuvenB-3000, Belgium</p><div>Find articles by <a href="/pubmed/?term=Vijgen%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">L. Vijgen</a></div></div><div id="_co_idm140139861777392"><h3 class="no_margin">P. Maes</h3><p><sup>3</sup>Raga Institute for Medical Research, Katholieke Universiteit-Leuven, Minder broederstraat 10, LeuvenB-3000, Belgium</p><div>Find articles by <a href="/pubmed/?term=Maes%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">P. Maes</a></div></div><div id="_co_idm140139861775168"><h3 class="no_margin">J. Neyts</h3><p><sup>3</sup>Raga Institute for Medical Research, Katholieke Universiteit-Leuven, Minder broederstraat 10, LeuvenB-3000, Belgium</p><div>Find articles by <a href="/pubmed/?term=Neyts%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">J. Neyts</a></div></div><div id="_co_idm140139861772944"><h3 class="no_margin">M. V. Ranst</h3><p><sup>3</sup>Raga Institute for Medical Research, Katholieke Universiteit-Leuven, Minder broederstraat 10, LeuvenB-3000, Belgium</p><div>Find articles by <a href="/pubmed/?term=Ranst%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20390088">M. V. Ranst</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140139900673776_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140139900673776_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140139900673776_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140139900673776_ai" style="display:none"><div class="fm-affl" lang="en" id="AF0001">Arulmigu Kalasalingam College of Pharmacy, Krishnankoil - 626 190, India</div><div class="fm-affl" lang="en" id="AF0002"><sup>1</sup>Institute of Pharmacology, Madurai Medical College, Madurai - 625 020, India</div><div class="fm-affl" lang="en" id="AF0003"><sup>2</sup>Bharat Ratna Kamarajar Liver Hospital and Research Center, Madurai - 625 001, Belgium</div><div class="fm-affl" lang="en" id="AF0004"><sup>3</sup>Raga Institute for Medical Research, Katholieke Universiteit-Leuven, Minder broederstraat 10, LeuvenB-3000, Belgium</div><div id="cor1"><sup>*</sup><strong>For correspondence</strong> E-mail: <a href="mailto:dev@null" data-email="ni.oc.oohay@1002mavlesymasayirep" class="oemail">ni.oc.oohay@1002mavlesymasayirep</a></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140139900673776_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2006 Jul 6; Revised 2007 Jul 23; Accepted 2008 Jan 29.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140139900673776_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Indian Journal of Pharmaceutical Sciences</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2852069/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140139828289856" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140139828289856title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N(4,6-dimethyl-2-pyrimidiny)benzene sulphonamide and its derivatives were evaluated for antiviral activity against Pathogenic viruses such as Hepatitis C Virus and SARS-CoV in Vero and Huh 5-2 cells, respectively. The 5-fluoro derivative inhibited the HCV RNA synthesis at 6 &#x003bc;g/ml, without toxicity at a concentration up to 42 &#x003bc;g/ml in Huh 5-2 cells. Among the compounds tested SPIII-5F exhibits the 45% maximum protection against replication of SARS-CoV in Vero cells.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Isatin, HCV, SARS-CoV, vero cells, huh 5-2 cells</span></div></div><div id="idm140139828287280" class="tsec sec headless whole_rhythm"><p id="__p2" class="p p-first">Isatin (2,3-dioxoindole), a versatile lead molecule for potential bioactive agents, and its derivatives were reported to posses anticancer<sup><a href="#CIT1" rid="CIT1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309879067">1</a></sup>, antibacterial activities<sup><a href="#CIT2" rid="CIT2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_222311453">2</a></sup><sup>&#x02013;</sup><sup><a href="#CIT4" rid="CIT4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_222311455">4</a></sup>. Methisazone (N-methylisatin-&#x003b2;-thiosemicarbazone) was one of the first clinically used synthetic antiviral agent<sup><a href="#CIT5" rid="CIT5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309879069">5</a></sup>. Isatin derivative were reported for antiviral activity against a verity of pathogens viruses<sup><a href="#CIT6" rid="CIT6" class=" bibr popnode">6</a></sup> and N,N-disubstitutedthiosemicarbazone derivative of isatin were tested for inhibition of HIV-1 replication<sup><a href="#CIT7" rid="CIT7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_222311451">7</a></sup>. Previously we reported synthesis of novel isatin derivatives and evaluated antiviral activity against HIV-1 and HIV-2 in MT-4 cells<sup><a href="#CIT8" rid="CIT8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_222311452">8</a></sup>. Significant antiviral activity was observed with these compounds against HIV-1 replication<sup><a href="#CIT9" rid="CIT9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_222311450">9</a></sup>.</p><p id="__p3">In view of the broad spectrum activities of isatin derivatives, we aimed at evaluating the antiviral activity of some novel 4-1[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N(4,6-dimethyl-2-pyrimidiny)-benzenesulphonamide and its derivatives (<a href="/pmc/articles/PMC2852069/figure/F0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="F0001" rid-ob="ob-F0001" co-legend-rid="lgnd_F0001"><span>fig. 1</span></a>) against pathogenic viruses such as hepatitis C virus (HCV) in human hepatoblastoma cells (Huh 5-2 cells) and Severe Acute Respiratory Syndrome corona virus (SARS-CoV) in Vero cultures.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F0001" co-legend-rid="lgnd_F0001"><a href="/pmc/articles/PMC2852069/figure/F0001/" target="figure" rid-figpopup="F0001" rid-ob="ob-F0001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140139899220880" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJPhS-70-91-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is IJPhS-70-91-g001.jpg" src="/pmc/articles/PMC2852069/bin/IJPhS-70-91-g001.jpg" /></div><div id="largeobj_idm140139899220880" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2852069/figure/F0001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F0001"><div><a class="figpopup" href="/pmc/articles/PMC2852069/figure/F0001/" target="figure" rid-figpopup="F0001" rid-ob="ob-F0001">Fig. 1</a></div><!--caption a7--><div class="caption"><p id="__p4">N-(4,6-dimethylpyridin-2-yl)-4-(2-oxo-1,2-dihydroindol-3- ylideneamino) benzenesulfonamide and its derivatives. R and R<sub>1</sub> for SPIII-5Br are Br and H, for SPIII-5Cl are Cl and H, for SPIII-5F are F and H, for SPIII-5H are H and H, for SPIII-Me are CH<sub>3</sub> and H and for SPIII-NA are H and COCH<sub>3</sub>, respectively.</p></div></div></div><p id="__p5">4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N(4,6-dimethyl-2-pyrimidiny)benzene sulphonamide and its derivatives (<a href="/pmc/articles/PMC2852069/figure/F0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="F0001" rid-ob="ob-F0001" co-legend-rid="lgnd_F0001"><span>fig. 1</span></a>) were prepared by condensing the isatin and its derivatives (5-chloro, 5-bromo, 5-flouro, 5-methyl and N-acetyl) with sulphadimidine in the presence of glacial acetic acid<sup><a href="#CIT9" rid="CIT9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_222311454">9</a></sup>.</p><p id="__p6">In the method adopted for antiviral activity against SARS-CoV in vero cells<sup><a href="#CIT10" rid="CIT10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845006093">10</a></sup>. Vero E6 cells in 96-well tissue culture plates were used confluent. Culture medium was removed and 100 &#x003bc;L of minimum essential medium supplemented with 2% fetal bovine serum containing an appropriate concentration of antiviral compound was added. Inside a biosafety laboratory-3,25 &#x003bc;L of a SARS-CoV virus solution added. Five concentrations were tested for cytotoxicity of the antiviral compounds. After an incubation period of three days at 37&#x000b0; in 5% CO<sub>2</sub>, the inhibition of the cytopathic effect (CPE) by the compounds was measured in a spectrophotometer (at 492) by the reduction by cellular dehydrogenase of the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrzolium(MTS) dye (Cell titer 96 Aqueous One Solution kit, promega) (20 &#x003bc;L MTS for 3h at 37&#x000b0;) in to a water soluble coloured formazan product. The antiviral activity and cytotoxcity of the test compounds are presented in <a href="/pmc/articles/PMC2852069/table/T0001/" target="table" class="fig-table-link figpopup" rid-figpopup="T0001" rid-ob="ob-T0001" co-legend-rid=""><span>Table 1</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T0001"><h3>TABLE 1</h3><!--caption a7--><div class="caption"><p id="__p7">ANTIVIRAL ACTIVITY OF ISATIN DERIVATIVE AGAINST SARS-COV IN VERO E6 CELLS</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140139831309008" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Compound code</th><th align="center" rowspan="1" colspan="1">EC<sub>50</sub><sup>a</sup> (&#x003bc;g/ml)</th><th align="center" rowspan="1" colspan="1">CC<sub>50</sub><sup>b</sup> (&#x003bc;g/ml)</th><th align="center" rowspan="1" colspan="1">Maximum protection (%) (at 125 &#x003bc;g/ml)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">5CI-IS-AC</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5H</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5Cl</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5Br</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5F</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">45</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5Me</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-NA</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">&#x0003e;125</td><td align="center" rowspan="1" colspan="1">12</td></tr></tbody></table></div><div id="largeobj_idm140139831309008" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2852069/table/T0001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="T000F1"><sup>a</sup>50% effective concentration required to reduce virus-induced cytopathicity by 50%.</div><div id="T000F2"><sup>b</sup>50% cytotoxic concentration required to reduce host cell viability by 50%</div></div></div><p id="__p10">Replication assay undertaken with Huh-5-2 cells<sup><a href="#CIT11" rid="CIT11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309879068">11</a></sup><sup>&#x02013;</sup><sup><a href="#CIT13" rid="CIT13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_222311457">13</a></sup> [a cell line with a persistent HCV replication 1389luc-ubi-neo/NS3-3/5.1; replication with firefly luciferase-lubquitin-neomycine phosphotransferase fusion protein EMCV-IRES drivan NS3-5B HCV polyprotein] was cultured in RPMI medium 2 mM glutamine, 1&#x000d7; non essential amino acid (Life Technologies, DC); 100 IU/ml penicillin and 100 &#x003bc;g/ml streptomycin and 250 &#x003bc;g/ml G418 (Geneticin, Life Technologies Washington DC). Cells were seeded at a density of 7000 cells per well in 96 well view plate TM (Packard, CA) in medium containing the same compounds as described above, except for G418. Cells were allowed to adhere and proliferate for 24 h. At that time, culture was removed and serial dilution of test compounds were added in culture medium lacking G418. Interferon alfa 2a (500 IU) was added as a positive control. Plates were further incubated at 37&#x000b0; and 5% CO<sub>2</sub> for 72 h replication of HCV replicon in Huh-5 cells results in luciferase activity in the cells. Luciferase activity was measured by adding 50 &#x003bc;l of 1 &#x000d7; Gloysis buffer (Promega) for 15 min of followed by adding 50 &#x003bc;l Steady-Glo Luciferase assay reagent (promega). Luciferase activity was measured with luminometer and signal in each individual well was expressed as a percentage of the untreated culture. Parallel culture of Huh 5-2 cells, seeded at a density of 7000 cells/well of classical 96-well cell culture plates (Becton-Dicknson) were treated in a similar fashion except that no Glo-lysis buffer or Stady-Glo Luciferase reagent was added. Instead the density of the cluture was measured by means of the MTS method (Promega). The antiviral activity and cytotoxicity of the test compounds are prepared in <a href="/pmc/articles/PMC2852069/table/T0002/" target="table" class="fig-table-link figpopup" rid-figpopup="T0002" rid-ob="ob-T0002" co-legend-rid=""><span>Table 2</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T0002"><h3>TABLE 2</h3><!--caption a7--><div class="caption"><p id="__p11">ANTI-HCV ACTIVITY OF ISATIN DERIVATIVES</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140139862162192" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Compound code</th><th align="center" rowspan="1" colspan="1">EC<sub>50</sub> (&#x003bc;g/ml) HCV RNA<sup>*</sup></th><th align="center" rowspan="1" colspan="1">CC<sub>50</sub> (&#x003bc;g/ml) Cell growth<sup>*</sup></th><th align="center" rowspan="1" colspan="1">SI</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">5CI-IS-AC</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5H</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">&#x0003e;2</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5CI</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5BR</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">&#x0003e;3</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5F</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-5Me</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">SPIII-NA</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">&#x0003e;50</td><td align="center" rowspan="1" colspan="1">0</td></tr></tbody></table></div><div id="largeobj_idm140139862162192" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2852069/table/T0002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="T000F3"><sup>*</sup>% untreted control. Interferon alfa-2b at 10.000 units/well reduced the signal in the viral RNA (luciferase) assay to background levels; without any cytostatic activity</div></div></div><p id="__p13">From the antiviral and cytotoxicity assay it was observed that the compounds 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N(4,6-dimethyl-2-pyrimidiny)benzene sulphonamide (SPIII-5H) and bromo derivative (SPIII-Br) inhibits HCV RNA synthesis at the EC<sub>50</sub> of 17 and 19 &#x003bc;g/ml, respectively while its CC<sub>50</sub> for cell growth was 42 &#x003bc;g/ml in Huh 5-2 cells. The isatin lead molecule 5Cl-IS-AC did not inhibit the HCV RNA synthesis (EC<sub>50</sub> and CC<sub>50</sub> more than 50 &#x003bc;g/ml) and the replication of SARS-CoV (maximum protection 0%). SPIII derivative showed 2-45% maximum protection against the replication of SARS-CoV in Vero cells and compound SPIII 5F exhibited 45% maximum protection against the replication of acutely infected SARS-CoV in Vero cell.</p><p id="__p14">The present study was aimed at investigating some novel isatin derivative for antiviral activities against HCV and SARS-CoV to identify potential bioactive agent in the series. From the results of biological activities it appeared that some of the derivatives showed antiviral activity against HCV virus in Huh 5-3 cells.SPIII-5H and bromo derivatives inhibited the synthesis of HCV RNA, but only at a relatively high concentration (17 and 19 &#x003bc;l/ml).</p><p id="__p15" class="p p-last">In the present study, the test compound SPIII-5F inhibited the HCV RNA synthesis in Huh 5-2 Cells (SI=7) and 45% maximum protection against the replication against the replication of acutely infected SARS-CoV in Vero cells (<a href="/pmc/articles/PMC2852069/table/T0001/" target="table" class="fig-table-link figpopup" rid-figpopup="T0001" rid-ob="ob-T0001" co-legend-rid=""><span>Table 1</span></a> and <a href="/pmc/articles/PMC2852069/table/T0002/" target="table" class="fig-table-link figpopup" rid-figpopup="T0002" rid-ob="ob-T0002" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and2).</span></span><span>2</span></a>). Isatin lead molecule (5CI-IS-AC) did not inhibit the HCV RNA synthesis and replication of SARS-CoV. Presence of sulphonamide side chain in the 3<sup>rd</sup> position was essential for antiviral activity (SPIII-5H, 5Br and 5F). Further modification in the series may help in optimizing antiHCV activity.</p></div><div id="idm140139901621712" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140139901621712title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140139901621584"><p id="__p16" class="p p-first-last"><strong>Selvam, <em>et al</em>.: <em>In Vitro</em> Antiviral Activity of Isatin Derivatives</strong></p></p></div></div><div id="idm140139901619824" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140139901619824title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CIT1">1. <span class="element-citation">Popp FD. Synthesis of potential anti-neoplastic agents, XX: Compounds related to the 3-o-nitrophenylhydrazone of isatin. <span><span class="ref-journal">J Pharm Sci. </span>1969;<span class="ref-vol">12</span>:182\xe2\x80\x934.</span> [<a href="/pubmed/5763024" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Sci&amp;title=Synthesis+of+potential+anti-neoplastic+agents,+XX:+Compounds+related+to+the+3-o-nitrophenylhydrazone+of+isatin&amp;author=FD+Popp&amp;volume=12&amp;publication_year=1969&amp;pages=182-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT2">2. <span class="element-citation">Varma RS, Nobles WL. Synthesis and Antiviral and Antibacterial Activity of Certain N-Dialkylaminomethylisatin &#x003b2;-Thiosemicarbazones. <span><span class="ref-journal">J Med Chem. </span>1967;<span class="ref-vol">10</span>:972\xe2\x80\x934.</span> [<a href="/pubmed/4292737" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Chem&amp;title=Synthesis+and+Antiviral+and+Antibacterial+Activity+of+Certain+N-Dialkylaminomethylisatin+&#x003b2;-Thiosemicarbazones&amp;author=RS+Varma&amp;author=WL+Nobles&amp;volume=10&amp;publication_year=1967&amp;pages=972-4&amp;pmid=4292737&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT3">3. <span class="element-citation">Pandeya SN, Sriram D, De Clercq E, Pannecouque C, Witvrouw M. Anti-HIV activity of some Mannich bases of isatin derivatives. <span><span class="ref-journal">Indian J Pharm Sci. </span>1998;<span class="ref-vol">60</span>:207\xe2\x80\x9312.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Indian+J+Pharm+Sci&amp;title=Anti-HIV+activity+of+some+Mannich+bases+of+isatin+derivatives&amp;author=SN+Pandeya&amp;author=D+Sriram&amp;author=E+De+Clercq&amp;author=C+Pannecouque&amp;author=M+Witvrouw&amp;volume=60&amp;publication_year=1998&amp;pages=207-12&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT4">4. <span class="element-citation">Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV activities of Norfloxacin Mannich bases. <span><span class="ref-journal">Eur J Med Chem. </span>2000;<span class="ref-vol">35</span>:249\xe2\x80\x9355.</span> [<a href="/pubmed/10758286" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Med+Chem&amp;title=Synthesis,+antibacterial,+antifungal+and+anti-HIV+activities+of+Norfloxacin+Mannich+bases&amp;author=SN+Pandeya&amp;author=D+Sriram&amp;author=G+Nath&amp;author=E+De+Clercq&amp;volume=35&amp;publication_year=2000&amp;pages=249-55&amp;pmid=10758286&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT5">5. <span class="element-citation">Bauer DJ, Sadler PW. The structure-activity relationships of the antiviral chemotherapeutic activity of isatin &#x003b2;-thiosemicarbazone. <span><span class="ref-journal">Br Pharm Chemother. </span>1960;<span class="ref-vol">15</span>:101\xe2\x80\x9310.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1481969/">PMC free article</a>]</span> [<a href="/pubmed/13797622" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+Pharm+Chemother&amp;title=The+structure-activity+relationships+of+the+antiviral+chemotherapeutic+activity+of+isatin+&#x003b2;-thiosemicarbazone&amp;author=DJ+Bauer&amp;author=PW+Sadler&amp;volume=15&amp;publication_year=1960&amp;pages=101-10&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT6">6. <span class="element-citation">Wolf ME.  <span class="ref-journal">Antiviral agents: Burger Medicinal Chemistry.</span> 4th ed., Part-II. New York: John Wiley and Sons; 1979. p. 553. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Antiviral+agents:+Burger+Medicinal+Chemistry&amp;author=ME+Wolf&amp;publication_year=1979&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT7">7. <span class="element-citation">Teitz Y, Ronen D, Vansover A, Stematsky T, Rigg JL. Inhibition of human immunodeficiency virus by N-methylisatin-&#x003b2;-4\':4\' diethylthiosemicarbazone and N-allyl isatin-&#x003b2;-4\':4\' diallylthiosemicarbazone. <span><span class="ref-journal">Antiviral Res. </span>1994;<span class="ref-vol">24</span>:305\xe2\x80\x9314.</span> [<a href="/pubmed/7993075" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antiviral+Res&amp;title=Inhibition+of+human+immunodeficiency+virus+by+N-methylisatin-&#x003b2;-4\':4\'+diethylthiosemicarbazone+and+N-allyl+isatin-&#x003b2;-4\':4\'+diallylthiosemicarbazone&amp;author=Y+Teitz&amp;author=D+Ronen&amp;author=A+Vansover&amp;author=T+Stematsky&amp;author=JL+Rigg&amp;volume=24&amp;publication_year=1994&amp;pages=305-14&amp;pmid=7993075&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT8">8. <span class="element-citation">Pauwels R, Balzarini J, Baba M, Snoeck R, Schols DJ, Herdewijin P, et al.  Rapid and automated tetrazolium based colourimetric assay for the detection of anti-HIV compounds. <span><span class="ref-journal">J Virol Methods. </span>1988;<span class="ref-vol">20</span>:309\xe2\x80\x9321.</span> [<a href="/pubmed/2460479" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol+Methods&amp;title=Rapid+and+automated+tetrazolium+based+colourimetric+assay+for+the+detection+of+anti-HIV+compounds&amp;author=R+Pauwels&amp;author=J+Balzarini&amp;author=M+Baba&amp;author=R+Snoeck&amp;author=DJ+Schols&amp;volume=20&amp;publication_year=1988&amp;pages=309-21&amp;pmid=2460479&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT9">9. <span class="element-citation">Selvam P, Chandramohan M, De Clercq E, Pannecouque C, Witrouw M. Synthesis and anti-HIV activity of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene) amino]-N (4, 6-dimethyl-2-pyrimidinyl)-benzenesulphonamide and its derivatives. <span><span class="ref-journal">Eur J Pharm Sci. </span>2001;<span class="ref-vol">14</span>:313\xe2\x80\x936.</span> [<a href="/pubmed/11684405" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharm+Sci&amp;title=Synthesis+and+anti-HIV+activity+of+4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)+amino]-N+(4,+6-dimethyl-2-pyrimidinyl)-benzenesulphonamide+and+its+derivatives&amp;author=P+Selvam&amp;author=M+Chandramohan&amp;author=E+De+Clercq&amp;author=C+Pannecouque&amp;author=M+Witrouw&amp;volume=14&amp;publication_year=2001&amp;pages=313-6&amp;pmid=11684405&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT10">10. <span class="element-citation">Keyaerts E, vijgen L, Maes P, Neyts J, Ranst MV. <em>In vitro</em> inhibition of SARS-CoV Virus by Chloroquine, <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2004;<span class="ref-vol">323</span>:264\xe2\x80\x937.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7092815/">PMC free article</a>]</span> [<a href="/pubmed/15351731" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=In+vitro+inhibition+of+SARS-CoV+Virus+by+Chloroquine,&amp;author=E+Keyaerts&amp;author=L+vijgen&amp;author=P+Maes&amp;author=J+Neyts&amp;author=MV+Ranst&amp;volume=323&amp;publication_year=2004&amp;pages=264-7&amp;pmid=15351731&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT11">11. <span class="element-citation">Bartenschalager R. Hepatitis C virus replicons: Potential role for drug development. <span><span class="ref-journal">Nature Rev Drug Disc. </span>2002;<span class="ref-vol">1</span>:911\xe2\x80\x936.</span> [<a href="/pubmed/12415250" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Rev+Drug+Disc&amp;title=Hepatitis+C+virus+replicons:+Potential+role+for+drug+development&amp;author=R+Bartenschalager&amp;volume=1&amp;publication_year=2002&amp;pages=911-6&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT12">12. <span class="element-citation">Pietschman T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:1252\xe2\x80\x9364.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114031/">PMC free article</a>]</span> [<a href="/pubmed/11152498" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Characterization+of+cell+lines+carrying+self-replicating+hepatitis+C+virus+RNAs&amp;author=T+Pietschman&amp;author=V+Lohmann&amp;author=G+Rutter&amp;author=K+Kurpanek&amp;author=R+Bartenschlager&amp;volume=75&amp;publication_year=2001&amp;pages=1252-64&amp;pmid=11152498&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT13">13. <span class="element-citation">Lohmann V, Korner F, Koch J, Herian V, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis virus RNAs in a hepatoma cell line. <span><span class="ref-journal">Science. </span>1999;<span class="ref-vol">285</span>:110\xe2\x80\x933.</span> [<a href="/pubmed/10390360" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Replication+of+subgenomic+hepatitis+virus+RNAs+in+a+hepatoma+cell+line&amp;author=V+Lohmann&amp;author=F+Korner&amp;author=J+Koch&amp;author=V+Herian&amp;author=L+Theilmann&amp;volume=285&amp;publication_year=1999&amp;pages=110-3&amp;pmid=10390360&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2852069&amp;issue-id=186272&amp;journal-id=978&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Indian Journal of Pharmaceutical Sciences</span> are provided here courtesy of <strong>Wolters Kluwer -- Medknow Publications</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2852069/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2852069/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2852069/?report=printable">Printer Friendly</a></li> | <li><a href="#" data-citationid="PMC2852069" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852069%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852069%2F&amp;text=In%20Vitro%20Antiviral%20Activity%20of%20some%20Novel%20Isatin%20Derivatives%20against%20HCV%20and%20SARS-CoV%20Viruses"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852069%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="20390088" data-aiid="2852069" data-aid="2852069" data-iid="186272" data-domainid="978" data-domain="ijpharsci" data-accid="PMC2852069" data-md5="0ec1ec13a19c69b2c9fa29a9aafa4951"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:36:24-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B60A0E9A36DC10000000008830882&amp;ncbi_session=8A1B60A0E9A4B871_2179SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852069%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=ijpharsci&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2852069/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B60A0E9A4B871_2179SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'